A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social ...

Radiation therapy works by using high-energy X-rays to kill cancer cells. MSK offers precise radiation therapy that kills throat cancer cells with fewer side effects from radiatio ...

A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...

Groundbreaking cancer treatment is taking place at Albany Medical Center. New York Oncology Hematology offering CAR-T therapy, which stands for chimeric antigen receptor T-cell therapy. This treatment ...

As a world leader in the immuno-oncology field, Dr. Zihai Li has long been at the forefront of cancer immunotherapy.

Dr. Daniel E. Wong, Sutter Health Plastic & Reconstructive Surgeon | Credit: CourtesyDr. H. Katherine Kim, Sutter Health Radiation Oncologist | Credit: ...

Cancer treatments can have unintended consequences for the heart. Our Cardio-Oncology program helps minimize this risk by providing highly specialized cardiovascular care to cancer patients. We offer ...

FDA grants priority review to T-DXd for high-risk HER2-positive early breast cancer with residual disease, after trial shows markedly better recurrence-free survival than T-DM1.

Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.

After getting engaged, the only words journalist Mrinali Dhembla expected to hear were “I do.” Instead, she was told, “You have cancer.” “When I first heard the words, ‘You have cancer,’ I was ...

Toxicity-related T-DXd discontinuation was 15%, closely aligning with DESTINY-Breast04 (16.2%), supporting feasibility of administration in community oncology despite higher real-world disease burden.